Jeffrey Zonder
6PUBLICATIONS
33CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jun 16, 2024
Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma.Naresh Bumma, Joshua Richter, Sundar Jagannath
|Feb 02, 2023
A phase I study of selinexor combined with weekly carfilzomib and dexamethasone in relapsed/refractory multiple myeloma.Benjamin A Derman, Ajai Chari, Jeffrey Zonder
|May 30, 2020
Variability in Cytogenetic Testing for Multiple Myeloma: A Comprehensive Analysis From Across the United States.Yang Yu, Niquelle Brown Wade, Amie E Hwang
|May 25, 2019
Phase 1 study of selinexor plus carfilzomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma.Andrzej J Jakubowiak, Jagoda K Jasielec, Cara A Rosenbaum
|Jun 26, 2018
Daratumumab proves safe and highly effective in AL amyloidosis.Jack Khouri, Andrew Kin, Bicky Thapa
|May 17, 2018
The difficult business of assessing new therapies for smouldering multiple myeloma.Jeffrey A Zonder
Pageof 1
Frequent Collaborators
1 joint publications
Andrzej J Jakubowiak
1 joint publications
Cara A Rosenbaum
1 joint publications
Niquelle Brown Wade
1 joint publications
Amie E Hwang
1 joint publications
Ajay K Nooka
1 joint publications
Mark A Fiala
1 joint publications
David J Van Den Berg
1 joint publications
Daniel Auclair
1 joint publications
Ravi Vij
1 joint publications
Carol A Huff
